BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21745664)

  • 21. Use of misoprostol in third stage of labour.
    Khan R; Sharma S
    Lancet; 2002 Feb; 359(9307):708-9; author reply 709-10. PubMed ID: 11879892
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: reducing postpartum hemorrhage in Vietnam: assessing the effectiveness of active management of third-stage labor.
    Mahajan NN; Mahajan KN; Soni RN
    J Obstet Gynaecol Res; 2007 Oct; 33(5):743. PubMed ID: 17845342
    [No Abstract]   [Full Text] [Related]  

  • 23. Misoprostol for preventing PPH: some lessons learned.
    Chong YS; Su LL
    Lancet; 2006 Oct; 368(9543):1216-8. PubMed ID: 17027709
    [No Abstract]   [Full Text] [Related]  

  • 24. Commentary: Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health.
    Millard C; Pollock AM; Brhlikova P
    BMJ; 2014 Jul; 349():g4823. PubMed ID: 25081251
    [No Abstract]   [Full Text] [Related]  

  • 25. Misoprostol for postpartum haemorrhage.
    Drug Ther Bull; 2010 Jun; 48(6):66-9. PubMed ID: 20530028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
    Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings.
    Bradley SE; Prata N; Young-Lin N; Bishai DM
    Int J Gynaecol Obstet; 2007 Apr; 97(1):52-6. PubMed ID: 17316646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
    Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
    Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers or gaps in implementation of misoprostol use for post-abortion care and post-partum hemorrhage prevention in developing countries: a systematic review.
    Samnani AABA; Rizvi N; Ali TS; Abrejo F
    Reprod Health; 2017 Oct; 14(1):139. PubMed ID: 29078777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral misoprostol versus injectable methylergometrine in management of the third stage of labor.
    Garg P; Batra S; Gandhi G
    Int J Gynaecol Obstet; 2005 Nov; 91(2):160-1. PubMed ID: 16126208
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary on 'Community-based distribution of misoprostol: is this the way forward?'.
    Mathai M
    BJOG; 2014 Feb; 121(3):325-6. PubMed ID: 24575434
    [No Abstract]   [Full Text] [Related]  

  • 32. Misoprostol for postpartum hemorrhage: moving from evidence to practice.
    Starrs A; Winikoff B
    Int J Gynaecol Obstet; 2012 Jan; 116(1):1-3. PubMed ID: 22078140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing postpartum hemorrhage in Africa.
    Lazarus JV; Lalonde A
    Int J Gynaecol Obstet; 2005 Jan; 88(1):89-90. PubMed ID: 15617720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
    Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
    Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandins for the prevention of PPH.
    Anderson T
    Pract Midwife; 2005; 8(7):43-5. PubMed ID: 16044995
    [No Abstract]   [Full Text] [Related]  

  • 36. Postpartum hemorrhage in the developed world: whither misoprostol?
    Gibbins KJ; Albright CM; Rouse DJ
    Am J Obstet Gynecol; 2013 Mar; 208(3):181-3. PubMed ID: 22901709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Misoprostol and active management of the third stage of labor.
    Prata N; Hamza S; Gypson R; Nada K; Vahidnia F; Potts M
    Int J Gynaecol Obstet; 2006 Aug; 94(2):149-55. PubMed ID: 16828767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of two uterotonic medications for the management of the third stage of labor.
    Kushtagi P; Verghese LM
    Int J Gynaecol Obstet; 2006 Jul; 94(1):47-8. PubMed ID: 16762355
    [No Abstract]   [Full Text] [Related]  

  • 39. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan.
    Smith JM; Dimiti A; Dwivedi V; Ochieng I; Dalaka M; Currie S; Luka EE; Rumunu J; Orero S; Mungia J; McKaig C
    Int J Gynaecol Obstet; 2014 Nov; 127(2):183-8. PubMed ID: 25051905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of postpartum hemorrhage with misoprostol.
    International Federation Of Gynecology And Obstetrics
    Int J Gynaecol Obstet; 2012 Dec; 119(3):215-6. PubMed ID: 23036964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.